P641: REAL-WORLD DURATION OF VENETOCLAX TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA

• Anna Teschemaker,
• Shweta Hakre,
• Jenny Tse,
• Nazneen Fatima Shaikh,
• Yifan Gu,
• Aimee Near

Affiliations

Anna Teschemaker

1 AstraZeneca Pharmaceuticals, Global Medical Affairs, Gaithersburg, United States

Shweta Hakre

2 AstraZeneca Pharmaceuticals, US Medical Affairs, Gaithersburg, United States

Jenny Tse

3 IQVIA, Cambridge, United States

Nazneen Fatima Shaikh

3 IQVIA, Cambridge, United States

Yifan Gu

3 IQVIA, Cambridge, United States

Aimee Near

3 IQVIA, Cambridge, United States